[1] Jin SM, Kim KW. Is islet transplantation a realistic approach to curing diabetes?[J].Korean J Intern Med,2017,32(1):62-66. [2] Fiorina P, Gremizzi C, Maffi P,et al. Islet transplantation is associated with an improvement of cardiovascular function in type1 diabetic kidney transplant patients[J]. Diabetes Care, 2005, 28(6):1358-1365. [3] Wang H, Zhang W, Cai H. α-Cell loss from islet impairs its insulin secretion in vitro and in vivo[J]. Islets, 2011, 3(2):58-65. [4] Kang H, Han K, Jo J,et al. Systems of pancreatic beta-cells and glucose regulation[J]. Front Biosci, 2008, 13(1):6421-6431. [5] Petrenko V, Saini C, Giovannoni L. Pancreatic α-and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression[J]. Genes Dev, 2017,31(4):383-398. [6] Kanno T, Gopel SO, Rorsman P, et al. Cellular function in multicellular system for hormone-secretion:electrophysiological aspect of studies on alpha-, beta-and delta-cells of the pancreatic islet[J]. Neurosci Res,2002, 42(2):79-90. [7] Pipeleers D, Int P, Maes E. Glucose-induced insulin release depends on functional cooperation between islet cells[J]. Proc Natl Acad Sci, 1982, 79(23):7322-7325. [8] Fujita Y, Wideman RD, Asadi A, et al. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion[J]. Gastroenterology, 2010,138(5):1966-1975. [9] Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose[J]. Diabetes, 2000,49(11):1751-1760. [10] Calanna S, Christensen M, Holst JJ, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus:systematic review and meta-analyses of clinical studies[J]. Diabetologia, 2013,56(5):965-972. [11] Gomez E, Pritchard C, Herbert TP. cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells[J]. J Biol Chem, 2002, 277(50):48146-48151. [12] Tourrel C, Bailbe D, Lacorne M, et al. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4[J]. Diabetes, 2002, 51(5):1443-1452. [13] Trevaskis JL, Sacramento CB, Jouihan H, et al. Neurturin and a Glp-1 analogue act synergistically to alleviate diabetes in Zucker Diabetic Fatty Rats[J]. Diabetes, 2017, doi:10.2337/db16-0916. [14] Traub S, Meier DT, Schulze F, et al. Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis[J]. Cell Rep,2017, 18(13):3192-3203. [15] Keymeulen B, Korbutt G, De Paepe M, et al. Long-term metabolic control by rat islet grafts depends on the composition of the implant[J]. Diabetes, 1996, 45(12):1814-1821. [16] Halden TA, Egeland EJ, Åsberg A,et al. GLP-1 restores altered insulin and glucagon secretion in posttransplantation diabetes[J]. Diabetes Care,2016,39(4):617-624. |